Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

This Week's Healthcare Earnings: Moderna, CVS, Hims & Hers No Photo Available

Yeji Jesse Lee

Macro-headwinds continued to cloud over earnings calls this week as a smattering of companies, including Humana, Moderna and Teladoc, ... (more story)

New Suits Target HHS Cuts, PBM Rates And Med. Device Regs No Photo Available

Gianna Ferrarin

The Trump administration is facing a wave of new allegations over its restructuring of the Department of Health and Human Services, wi... (more story)

What's Ahead For FDA Enforcement: 3 Things To Watch No Photo Available

Dan McKay

Companies regulated by the FDA should remain vigilant and expect scrutiny under the new Trump administration, not just from the agency... (more story)

极速赛车